2Valdespino V M,Valdespino V E.Cervical cancer screening:State of the art[J].Curr Opin Obstet Gynecol,2006,18(1):35-40.
3Scheurer M E,Tortdero L G,Adler S K.Human papillomavirus infection:Biology,epidemiology and prevention[J].Int J Gynecol Cancer,2005,15(5):727-746.
4Seung H S,Jae k L,Oye S S.The relationship between cytokines and HPV-16,HPV-16 E6,E7 and high-risk HPV viral load in the uterine cervix[J].Gynecol Oncol,2007,104(3):732-738.
5Zimmerman,Richard K.HPV vaccine and its recommendations[J].Family Practice,2007,56(2):S1-S5.
6Nucci,Marisa R,Crum,et al.Redefining early cervical neoplasia:Recent progress[J].Advances in Anatomic Pathology,2007,14(1):1-10.
7Narisawa S M,Handa K,Yugawa T,et al.HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes[J].Oncogene,2007,26(21):2988-2996.
8Subramanyam,Deepa,Krishna.C-myc substitutes for Notch1-CBF1 functions in cooperative transformation with papillomavirus oncogenes[J].Virology,2006,347(1):191-198.
9Karin M L.The Fos family of transcription factors and their role in tumourigenesis[J].Eur J Cancer,2005,41(16):2449-2461.
10Sumonmal M,Sumalee S,Surapan K,et al.Association between Bcl-2 expression and tumor recurrence in cervical cancer:A matched case-control study[J].Gynecol Oncol,2006,102(2):263-269.
